1:30 PM
Nov 13, 2017
 |  BC Extra  |  Financial News

Alnylam proposes $675M follow-on

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) proposed on Monday to raise $675 million in a follow-on underwritten by Goldman Sachs, JPMorgan, Barclays and Credit Suisse.

Also on Monday, Alnylam said EMA granted accelerated assessment to patisiran (ALN-TTR02) to treat...

Read the full 163 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >